30 May, EOD - Indian

SENSEX 81451.01 (-0.22)

Nifty 50 24750.7 (-0.33)

Nifty Bank 55749.7 (0.37)

Nifty IT 37321.75 (-1.15)

Nifty Midcap 100 57420 (-0.06)

Nifty Next 50 66761.3 (-0.50)

Nifty Pharma 21442.05 (-0.68)

Nifty Smallcap 100 17883.3 (-0.03)

30 May, EOD - Global

NIKKEI 225 37965.1 (-1.22)

HANG SENG 23289.77 (-1.20)

S&P 5925.75 (-0.15)

Login/Signup
Careers
LOGIN HERE
Cancel

companylogoSuraksha Diagnostic Ltd

You are Here : Home > Markets > CompanyInformation > Board Meeting
BSE Code : 544293 | NSE Symbol : SURAKSHA | ISIN : INE877V01027 | Industry : Healthcare |


Board Meeting
Announcement Date Date Of Meeting Purpose Detail
21-May-2025 28-May-2025 Final Dividend Suraksha Diagnostic Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2025 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 this is to inform you that a meeting of Board of Directors of the Company is scheduled to be held on Wednesday 28 May 2025 at the registered office of the Company to inter-alia consider and approve the audited (standalone and consolidated) financial results of the Company for the quarter and financial year ended 31 March 2025. and to consider recommendation of dividend if any on equity shares of the Company for the financial year ended 31 March 2025. Outcome of Board meeting held on 28 May 2025 inter-alia for approval of financial results for the quarter and financial year ended 31 March 2025. (As Per BSE Announcement Dated on :28.05.2025)
27-Mar-2025 27-Mar-2025 Acquisitions Information about acquisition
03-Feb-2025 08-Feb-2025 Quarterly Results Suraksha Diagnostic Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/02/2025 inter alia to consider and approve the unaudited standalone and consolidated financial results of the Company for the quarter and nine months ended 31 December 2024 1. The unaudited financial results (standalone and consolidated) of the Company for the quarter and nine months ended 31 December 2024 and the same is enclosed along with the Limited Review Report issued by the Statutory Auditors of the Company. 2. Appointment of Mr. Ravindra K S as the Chief Financial Officer with effect from 01 March 2025, who will also act as a Group Chief Financial Officer. 3. Amended Policies of the Company. (As Per Bse Announcement Dated on 08.02.2025)
14-Dec-2024 20-Dec-2024 Quarterly Results Suraksha Diagnostic Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/12/2024 inter alia to consider and approve Pursuant to Regulation 29(1)(a) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 this is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Friday 20 December 2024 at the registered office of the Company inter-alia to consider approve and take on record the unaudited standalone and consolidated financial results of the Company for the quarter and six months ended 30 September 2024. 1.Unaudited Financial Results (Standalone and Consolidated) of the Company for quarter and six months ended 30 September 2024; 2. Postal Ballot Notice for seeking shareholders' approval for the ratification of 'Suraksha Employee Stock Option Scheme 2024' ('ESOP 2024'/ 'Scheme')3. Formation of a Special Purpose Vehicle Company ('SPV') (As per BSE Announcement Dated on 20/12/2024) Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015 for incorporation of Suraksha Advanced Radiology Private Limited, Subsidiary of the Company. (As Per BSE Announcement dated on 22.01.2025)

Capital Market Publishers India Pvt. Ltd

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071, India.
+91-22-25229720
+91-9769005430
>info@capitalmarket.com

For any Capital Market Website related queries mail to :
webdesk@capitalmarket.com

For Capital Market Magazine subscription queries :
+91-8657545825  

subscription@capitalmarket.com

For Capital Market Online Product related queries :
+91-8657545825  

financeshop@capitalmarket.com

To advertise on Capital Market Websites mail to :
advt@capitalmarket.com

To email Press Releases :
pressrelease@capitalmarket.com

Kindly note www.capitalmarket.com does not send any mobile SMS, whatsapp or twitter messages giving any kind of stock recommendations.

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

Copyright @ Capital Market Publishers India Pvt.Ltd

Designed, Developed and maintained by CMOTS Infotech (ISO 9001:2015 Certified)

Site best viewed in Internet Explorer Edge ,   Google Chrome 115.0.5790.111 + ,   Mozilla Firefox 115.0.3 + ,   Opera 30.0+, Safari 16.4.1 +